Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 463 participants.

Also called NCT01319812

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 463 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01319812
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01319812. Non-randomized; no masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2015-09 (actual). Results posted on 2017-06-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Acronym
BIOFLEX-I
Condition
Peripheral Artery Disease
Condition
Peripheral Vascular Disease
Intervention (Device)
Astron Stents
Intervention (Device)
Pulsar Stents
Lead sponsor
Biotronik, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01319812
Content hash
e66a9f772056416ca6d5f2fbb1020fb8a182e6e397acb2ec67037d9087bdc4a3